BioXcel Therapeutics Inc (NASDAQ:BTAI)

34.94
Delayed Data
As of Apr 16
 -0.06 / -0.17%
Today’s Change
24.00
Today|||52-Week Range
71.50
-24.37%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 94.00, with a high estimate of 175.00 and a low estimate of 63.00. The median estimate represents a +169.03% increase from the last price of 34.94.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in BioXcel Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.95
Sales
$0.00
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.47%
 
 
 
 
 
 
Growthannually -12.79%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.